VAERS reports by lot

GSK Varicella/Shingles lot JC92P: VAERS reports

24 VAERS reports list lot JC92P as a GSK Varicella/Shingles vaccine, received between 2018-08-10 and 2022-01-12. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
24
Reports
4%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)3936%
Injection-site / Local reaction2221%
Neurological1716%
Gastrointestinal77%
Allergic / Anaphylactic66%
Musculoskeletal55%
Respiratory44%
Cardiac / Cardiovascular33%
Dermatological (non-injection-site)33%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Virginia3
Maryland3
Texas3
Michigan2
Missouri2
Maine1
Georgia1
New Jersey1
Illinois1
New York1
Washington1
Pennsylvania1

Reports by month received

2018-0810
2018-093
2018-106
2018-111
2018-121
2019-011
2019-031
2022-011

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.